Board Member
Ascend Wellness Holdings, Inc. (AAWH)Equibles does not estimate personal net worth.
Get an email with a short summary when Advanced Flower Capital Inc. publishes a filing, an earnings call transcript or a press release.
Get AFCG alertsDaniel Neville is recorded as CEO at Advanced Flower Capital Inc. (AFCG) and Board Member at Ascend Wellness Holdings, Inc. (AAWH) since November 23, 2022. The newest filing on record that lists Daniel Neville as CEO at Advanced Flower Capital Inc. (AFCG) is dated April 17, 2026. Advanced Flower Capital Inc. reported in an 8-K filed October 30, 2023 that Daniel Neville was appointed Chief Executive Officer, effective November 13, 2023. Ascend Wellness Holdings, Inc. reported in an 8-K filed May 9, 2023 that Daniel Neville resigned as director, effective May 15, 2023. Ascend Wellness Holdings, Inc. reported in an 8-K filed November 23, 2022 that Daniel Neville was appointed director, effective November 23, 2022. Equibles holds 4 filed executive changes naming Daniel Neville; each is listed under recent activity with its source filing. The proxy statement of Advanced Flower Capital Inc. reports total compensation of $750,001 for Daniel Neville in fiscal 2024. Disclosed compensation is on record for 5 fiscal years. Daniel Neville has spoken on 11 earnings calls across 1 company, most recently for Advanced Flower Capital Inc. on August 13, 2026. Advanced Flower Capital Inc. is classified in the Asset Management industry within the Financial Services sector. Ascend Wellness Holdings, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Advanced Flower Capital Inc. includes Leonard M. Tannenbaum (Chairman, CIO and Board Member), Leonard Tannenbaum (Chairman, CIO and Board Member), Brandon Hetzel (CFO) and 7 others.
“On October 26, 2023, the Board appointed Daniel Neville as the Chief Executive Officer of the Company and a member of its Investment Committee, effective as of November 13, 2023.”
“On May 8, 2023, Mr. Neville informed the Company that he will resign as a director of the Company, effective May 15, 2023.”
“I'll start with the portfolio and our investment activity for the quarter, then provide an update on our legacy positions and our pipeline.”
“I'll begin with an update on our expansion into private and update on our, as Len described, we feel good about the supply and demand dynamics in lower middle market lending and are excited about.”
“I'll begin with an update on our portfolio, then turn to our expanded strategy and deals we recently completed. Looking at our existing portfolio, from the beginning of 2025 through today, we received $117 million back in paydowns.”
“I'll begin with an overview of our results, followed by an update on our portfolio. For 2025, Advanced Flower Capital Inc. generated distributable earnings of $0.16 per basic weighted average share of common stock.”
“I'll begin with an overview of our results, followed by an update on our portfolio. For the second quarter of 2025, AFC generated distributable earnings of $0.15 per basic weighted average share of common stock.”
2022-11-23–present
Start not stated–present
Last confirmed April 17, 2026
2022-01-01–2023-05-15
Start not stated–2023-11-10
Asset Management · Financial Services
CEO
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2022-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Advanced Flower Capital Inc. (AFCG) | ( Chief Executive Officer ) | — | $750,001 |
| 2023 | Advanced Flower Capital Inc. (AFCG) | ( Chief Executive Officer ) | — | — |
| 2023 | Ascend Wellness Holdings, Inc. (AAWH) | Former Chief Financial Officer and Interim Co-Chief Executive Officer | $451,923 | $1,276,312 |
| 2022 | Ascend Wellness Holdings, Inc. (AAWH) | Former Chief Financial Officer and Interim Co-Chief Executive Officer | $500,000 | $1,444,025 |
| 2021 | Ascend Wellness Holdings, Inc. (AAWH) | Chief Financial Officer and Interim Co-Chief Executive Officer | $449,231 | $9,455,000 |
| 2020 | Ascend Wellness Holdings, Inc. (AAWH) | Chief Financial Officer and Interim Co-Chief Executive Officer | $276,923 | $561,731 |
